Subhash Padhye Selected Research

Coordination Complexes

10/2013	Targeting triple negative breast cancer cells by N3-substituted 9,10-phenanthrenequinone thiosemicarbazones and their metal complexes.
2/2010	Hybrid anticancer agents: isothiocyanate-progesterone conjugates as chemotherapeutic agents and insights into their cytotoxicities.
5/2004	The cytotoxicity and mechanisms of 1,2-naphthoquinone thiosemicarbazone and its metal derivatives against MCF-7 human breast cancer cells.
7/2003	Transition metal complexes of phenanthrenequinone thiosemicarbazone as potential anticancer agents: synthesis, structure, spectroscopy, electrochemistry and in vitro anticancer activity against human breast cancer cell-line, T47D.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Subhash Padhye Research Topics

Disease

46	Neoplasms (Cancer) 08/2022 - 04/2006
17	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018 - 06/2006
14	Breast Neoplasms (Breast Cancer) 08/2016 - 07/2003
5	Prostatic Neoplasms (Prostate Cancer) 04/2019 - 11/2006
5	Colonic Neoplasms (Colon Cancer) 08/2014 - 04/2011
4	Neoplasm Metastasis (Metastasis) 10/2023 - 06/2007
3	Ovarian Neoplasms (Ovarian Cancer) 09/2017 - 12/2016
3	Carcinogenesis 11/2016 - 04/2006
3	Colorectal Neoplasms (Colorectal Cancer) 11/2016 - 01/2014
2	Melanoma (Melanoma, Malignant) 01/2018 - 06/2004
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2017 - 12/2016
2	Leukemia 10/2015 - 09/2011
1	Lung Neoplasms (Lung Cancer) 10/2023
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021
1	Non-Muscle Invasive Bladder Neoplasms 01/2021
1	Radiation Fibrosis Syndrome (Radiation Fibrosis) 01/2018
1	Schizophrenia (Dementia Praecox) 01/2018
1	Fibrosis (Cirrhosis) 01/2018
1	Cardiomyopathies (Cardiomyopathy) 03/2016

Drug/Important Bio-Agent (IBA)

15	CurcuminIBA 09/2017 - 08/2009
8	NF-kappa B (NF-kB)IBA 09/2017 - 04/2006
7	CopperIBA 03/2011 - 07/2003
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 10/2007
5	MicroRNAs (MicroRNA)IBA 01/2018 - 01/2012
5	Estrogen ReceptorsIBA 08/2016 - 07/2003
5	Hyaluronic Acid (Hyaluronan)IBA 12/2015 - 05/2013
5	EnzymesIBA 08/2014 - 05/2012
5	thymoquinoneIBA 05/2013 - 01/2008
4	ThiosemicarbazonesIBA 10/2023 - 07/2005
4	ResveratrolIBA 08/2016 - 02/2013
4	Estrogens (Estrogen)FDA Link 01/2016 - 06/2005
4	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2014 - 10/2007
4	Coordination ComplexesIBA 10/2013 - 07/2003
4	Gemcitabine FDA Link 05/2013 - 04/2006
3	HydrazonesIBA 10/2023 - 05/2012
3	DNA (Deoxyribonucleic Acid)IBA 08/2022 - 01/2011
3	Phosphoric Monoester Hydrolases (Phosphatases)IBA 09/2017 - 12/2016
3	TensinsIBA 09/2017 - 12/2016
3	Folic Acid (Vitamin M)FDA LinkGeneric 09/2017 - 12/2016
3	LigandsIBA 01/2017 - 06/2004
3	3,4-difluorobenzylidenecurcuminIBA 12/2015 - 08/2015
3	Antineoplastic Agents (Antineoplastics)IBA 01/2015 - 07/2003
3	Proteins (Proteins, Gene)FDA Link 01/2015 - 06/2006
3	plumbaginIBA 07/2014 - 05/2012
3	garcinolIBA 01/2011 - 09/2009
3	Schiff Bases (Schiff Base)IBA 08/2009 - 11/2006
2	PhytochemicalsIBA 01/2021 - 07/2014
2	Matrix Metalloproteinases (MMPs)IBA 01/2018 - 01/2015
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 06/2007
2	ras ProteinsIBA 01/2018 - 01/2012
2	Messenger RNA (mRNA)IBA 01/2018 - 01/2014
2	MicellesIBA 09/2017 - 08/2015
2	Histones (Histone)IBA 01/2017 - 01/2011
2	Dendrimers (Dendrons)IBA 12/2016 - 12/2015
2	Poly(amidoamine)IBA 12/2016 - 12/2015
2	4- (E)- ((p- tolylimino)- methylbenzene- 1,2- diol)IBA 08/2016 - 01/2016
2	Phytoestrogens (Phytoestrogen)IBA 01/2016 - 10/2014
2	AcidsIBA 09/2015 - 09/2011
2	isothiocyanic acidIBA 08/2014 - 02/2010
2	SurvivinIBA 08/2014 - 07/2009
2	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 01/2014 - 05/2013
2	Phenol (Carbolic Acid)FDA Link 01/2014 - 05/2013
2	Transcription Factors (Transcription Factor)IBA 01/2013 - 06/2006
2	CytokinesIBA 01/2013 - 06/2007
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2011 - 07/2009
2	Hormones (Hormone)IBA 03/2011 - 06/2006
2	GenisteinIBA 06/2010 - 04/2006
2	IsoflavonesIBA 06/2010 - 04/2006
2	Proteasome InhibitorsIBA 08/2009 - 11/2006
1	Niacin (Nicotinic Acid)FDA LinkGeneric 10/2023
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2023
1	Isonicotinic Acids (Isonicotinic Acid)IBA 10/2023
1	QuercetinIBA 10/2023
1	Human Serum Albumin FDA LinkGeneric 01/2022
1	ChalconesIBA 01/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021
1	CateninsIBA 01/2021
1	AndrogensIBA 04/2019
1	Cyclin D1IBA 01/2018
1	CollagenIBA 01/2018
1	PiperidonesIBA 01/2018
1	asenapine FDA Link 01/2018
1	DiarylheptanoidsIBA 01/2018
1	Folate Receptor 1IBA 09/2017
1	poly(styrene-co-maleic anhydride)IBA 09/2017
1	TransferasesIBA 01/2017
1	AlbuminsIBA 01/2017
1	SuspensionsIBA 01/2017
1	FlavonoidsIBA 12/2016
1	3' Untranslated Regions (3' UTR)IBA 11/2016
1	5,8- dihydroxy- 3- methyl- 4- (9H)- naphtho(2,3- c)furanoneIBA 11/2016
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 11/2016
1	Mevalonic Acid (Mevalonate)IBA 11/2016
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2016
1	Tamoxifen FDA LinkGeneric 08/2016
1	Superoxides (Superoxide)IBA 03/2016

Therapy/Procedure

14	Therapeutics 08/2022 - 04/2006
2	Radiotherapy 01/2018 - 01/2012
2	Drug Therapy (Chemotherapy) 01/2012 - 04/2011
2	Chemoprevention 06/2007 - 04/2006